Loading clinical trials...
Loading clinical trials...
This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (steatohepatitis) as well as fibrosis in subjects with n...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Axcella Health, Inc
NCT04052516 · Non Alcoholic Steatohepatitis (NASH)
NCT04065841 · Non Alcoholic Steatohepatitis (NASH)
NCT02548351 · Non Alcoholic Steatohepatitis (NASH)
NCT02098317 · NAFLD, Non Alcoholic Steatohepatitis (NASH)
Cullman Clinical Trials
Cullman, Alabama
Adobe Clinical Research, LLC
Tucson, Arizona
Del Sol Research Management, LLC
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions